Evaluating the impact of body mass index in primary advanced or recurrent endometrial cancer patients with deficiency of mismatch repair protein, treated with dostarlimab plus chemotherapy: a retrospective observational study.

International Journal of Gynecological Cancer 2026

View at publisher
Authors: Eleonora Palluzzi, Amedeo Cefaliello, Olga Martelli, Luca Romano, Giordana Tiberi, Mariagrazia Distefano, Carolina Bottoni, Carolina Maria Sassu, Cláudia Marchetti, Anna Fagotti, Francesco Fanfani
DOI: 10.1016/j.ijgc.2025.103537
Cited by: 0

Fields of Study & Subjects

Endometrial and Cervical Cancer Treatments Cancer Risks and Factors Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
International Journal of Gynecological Cancer
Volume
36
Issue
2
Pages
103537–103537
Publication date
1 February 2026
Language
EN